ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 371,906 Value ($000) $5,727 Avg Close $19.92 Range $15.14 - $24.64

Q3 2025

Shares 340,482 Value ($000) $6,970 Avg Close $20.16 Range $17.43 - $24.38

Q2 2025

Shares 333,333 Value ($000) $6,687 Avg Close $18.93 Range $13.30 - $24.11

Q1 2025

Shares 11,160 Value ($000) $220 Avg Close $21.52 Range $18.67 - $25.37

Q4 2024

Shares 41,382 Value ($000) $931 Avg Close $25.92 Range $21.43 - $30.03

Q3 2024

Shares 138,006 Value ($000) $3,525 Avg Close $23.16 Range $20.63 - $27.67

Q2 2024

Shares 192,100 Value ($000) $4,489 Avg Close $21.05 Range $15.96 - $26.00

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	371,906	$5,727	$19.92	$15.14 - $24.64
Q3 2025	340,482	$6,970	$20.16	$17.43 - $24.38
Q2 2025	333,333	$6,687	$18.93	$13.30 - $24.11
Q1 2025	11,160	$220	$21.52	$18.67 - $25.37
Q4 2024	41,382	$931	$25.92	$21.43 - $30.03
Q3 2024	138,006	$3,525	$23.16	$20.63 - $27.67
Q2 2024	192,100	$4,489	$21.05	$15.96 - $26.00